Who owns CBIOWhat CBIO owns — n/a

Who owns CRESCENT BIOPHARMA, INC.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CBIO from SEC Form 13F filings across 64 reporting managers. All positions are from one synchronized reporting period — 2026-03-31 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-03-31 reporting period, 64 institutions disclosed 26.5M shares of CRESCENT BIOPHARMA, INC. worth $470.9M; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

13F holders

$470.9M

value, 2026 filers

26.5M

shares disclosed

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-03-31 · % of fund = share of the manager's own book · % of co. = share of CBIO's shares outstanding

#	Manager	Shares	Value	% of fund	% of co.	Δ shares QoQ
1	FMR LLC	4.1M	$75.9M	0.0%	—	—
2	BVF INC/IL	2.7M	$50.5M	1.6%	—	—
3	Fairmount Funds Management LLC	2.7M	$50.5M	3.6%	—	—
4	VR Adviser, LLC	2.1M	$39.2M	1.5%	—	—
5	FCPM III SERVICES B.V.	1.7M	$30.8M	4.3%	—	—
6	BALYASNY ASSET MANAGEMENT L.P.	1.5M	$27.7M	0.0%	—	—
7	Vestal Point Capital, LP	1.5M	$27.6M	0.8%	—	—
8	Opaleye Management Inc.	1.3M	$24.1M	3.2%	—	—
9	TANG CAPITAL MANAGEMENT LLC	1.2M	$21.3M	1.1%	—	—
10	VANGUARD CAPITAL MANAGEMENT LLC	801,395	$14.7M	0.0%	—	—
11	Logos Global Management LP	482,500	$8.9M	0.4%	—	—
12	Deep Track Capital, LP	453,686	$8.3M	0.1%	—	—
13	RTW INVESTMENTS, LP	372,856	$6.8M	0.1%	—	—
14	VANGUARD GROUP INC	557,506	$6.6M	0.0%	—	—
15	MILLENNIUM MANAGEMENT LLC	323,553	$5.9M	0.0%	—	—
16	PRICE T ROWE ASSOCIATES INC /MD/	303,551	$5.6M	0.0%	—	—
17	Point72 Asset Management, L.P.	300,000	$5.5M	0.0%	—	—
18	Alyeska Investment Group, L.P.	264,000	$4.8M	0.0%	—	—
19	GOLDMAN SACHS GROUP INC	228,475	$4.2M	0.0%	—	—
20	SUSQUEHANNA INTERNATIONAL GROUP, LLP	213,635	$3.9M	0.0%	—	—
21	PERCEPTIVE ADVISORS LLC	206,942	$3.8M	0.0%	—	—
22	MARSHALL WACE, LLP	200,780	$3.7M	0.0%	—	—
23	Exome Asset Management LLC	153,191	$2.8M	1.5%	—	—
24	Iguana Healthcare Management, LLC	100,000	$2.6M	1.7%	—	—
25	SILVERARC CAPITAL MANAGEMENT, LLC	130,500	$2.4M	0.2%	—	—

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.